Related Experiment Videos
Lack of progressive arteriopathy and stroke recurrence among children with cryptogenic stroke
Stephane Darteyre1, Stephane Chabrier, Emilie Presles
1Neuropédiatrie, CHU Montpellier, Hôpital Gui de Chauliac, Montpellier, France. stefdart@gmail.com
Insights
Cryptogenic arterial ischemic stroke (AIS) in children, unlike symptomatic AIS, showed no recurrence with aspirin treatment. These children also experienced better long-term neurologic outcomes.
Area of Science:
- Pediatric Neurology
- Vascular Neurology
- Stroke Medicine
Background:
- Arterial ischemic stroke (AIS) in children can be challenging to classify, with cryptogenic (unknown cause) and symptomatic (known cause) categories.
- Understanding the distinct outcomes and characteristics of these pediatric AIS subtypes is crucial for effective management and treatment strategies.
Purpose of the Study:
- To test the hypothesis that cryptogenic pediatric AIS presents better outcomes than symptomatic AIS.
- To compare the clinical and radiologic characteristics of cryptogenic versus symptomatic AIS in children.
Main Methods:
- A retrospective cohort study of 63 pediatric AIS inpatients (aged 0.25-16 years) between 1994-2007.
- Patients were categorized as cryptogenic (C) or symptomatic (S) AIS based on established cause.
- Outcomes were assessed by stroke recurrence rate and neurologic impairment score (NIS), with univariate analysis for comparisons.
Main Results:
- Cryptogenic AIS occurred in 44% of patients; symptomatic AIS in 56%.
- Group C demonstrated no stroke recurrence with aspirin (0% vs. 30.3% in S), a higher rate of nonprogressive arteriopathies (p=0.02), unilateral infarcts (p=0.01), and M1 segment stenosis (p=0.02).
- Cryptogenic AIS patients had better stroke outcomes (mean NIS 2.7 vs. 4.2; p=0.04).
Conclusions:
- Childhood cryptogenic AIS represents a distinct clinical and radiologic entity with potentially uniform pathophysiologic mechanisms.
- Early and sustained aspirin treatment appears to prevent recurrence in cryptogenic AIS cases.
Objective:
We hypothesized that cryptogenic forms of arterial ischemic stroke (AIS) in children may present better outcomes than symptomatic ones.
Methods:
We conducted a single-centered retrospective cohort study using chart reviews of all inpatients aged 0.25-16 years and admitted for AIS or TIA between 1994 and 2007. Sixty-three consecutive children with AIS were divided into 2 stroke categories: first, AIS with an established cause, considered as symptomatic (S), and second, AIS only associated with risk factors, and considered as cryptogenic (C). AIS were further subclassified according to the CASCADE stroke classification system. We measured long-term outcome with 2 endpoints: recurrence rate and neurologic impairment score (NIS). We used univariate analysis to compare the clinical and radiologic characteristics of both groups.
Results:
AIS were cryptogenic in 28 patients (44%) and symptomatic in 35 (56%). Compared to patients in group S, patients in group C showed an absence of stroke recurrence under prolonged aspirin treatment (0% vs 30.3%; p < 0.01), a predominance of nonprogressive arteriopathies (p = 0.02), unilateral infarcts (p = 0.01), M1 segment stenosis (p = 0.02), and better stroke outcomes (mean NIS 2.7 vs 4.2; p = 0.04). Within group C, patients with post-varicella arteriopathy (PVA) had a profile comparable to that of patients with non-PVA strokes in terms of infarct topography, localization of vascular lesions, recurrence rate, and neurologic outcome.
Conclusion:
Cryptogenic AIS during childhood is a homogeneous clinical and radiologic entity, likely reflecting similar underlying pathophysiologic mechanisms. Under early and prolonged treatment with aspirin, cryptogenic AIS does not recur.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Hemorrhagic Stroke l: Introduction
Transient Ischemic Attack l: Introduction